Do genetic risk loci identified in the study apply to endometrial cancer polyps?
The question asks whether genetic risk loci identified in a genome-wide association study (GWAS) of female genital tract polyps also apply to endometrial cancer. The study found 52 risk loci for polyps, some of which overlap with endometrial cancer risk through shared biology, but the loci were identified specifically for polyps, not for cancer. Endometrial cancer and polyps are distinct conditions, though they may share some genetic factors.
What the research says
A large GWAS meta-analysis identified 52 genetic risk loci for female genital tract polyps, including 36 novel ones 5. The study found that these loci are involved in DNA replication, hormone-driven proliferation, and estrogen metabolism 5. Importantly, Mendelian randomization analyses showed bidirectional causal relationships between polyps and endometrial cancer, indicating shared genetic architecture 5. However, the loci were discovered in women with polyps, not in those with endometrial cancer. Other studies have identified mutations in TP53 and PTEN in endometrial cancer samples 1, and type 2 diabetes is associated with increased endometrial cancer risk 6, but these are different from the polyp risk loci. The polyp study itself notes that leveraging shared genetics with other gynecological disorders revealed additional loci, including some linked to cancer 5. So while the loci are primarily for polyps, some may influence endometrial cancer risk indirectly.
What to ask your doctor
- Do the genetic risk loci for polyps increase my risk for endometrial cancer?
- Should I have genetic testing for the loci mentioned in the polyp study?
- How do my personal risk factors (like diabetes or family history) affect my endometrial cancer risk?
- Are there any screening recommendations for endometrial cancer if I have polyps?
This question is drawn from common patient questions about this topic and answered using cited medical research. We do not provide individualized advice.